Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Thread by @edgarvlermamd: .@goKDIGO Consensus Conference on

KDIGO - This week's KDIGO GN Speaker's Guide feature is Nephrotic

Edgar V. Lerma 🇵🇭 on X: Membranous Nephropathy: 2 important

Edgar V. Lerma 🇵🇭 on X: What are the relevant publications that

Edgar V. Lerma 🇵🇭 on X: .@goKDIGO Glomerular Diseases Guideline

Edgar V. Lerma 🇵🇭 ಮೇಲೆ X: CKD-aP (CKD associated pruritus

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Edgar V. Lerma 🇵🇭 on X: FSGS ca. 2021 from @Kidney_Int @goKDIGO

Edgar V. Lerma 🇵🇭 on X: Pathogenesis based approach to

Edgar V. Lerma 🇵🇭 on X: Integrated approach to interpret

Edgar V. Lerma 🇵🇭 on X: Membranous Nephropathy: 2 important